ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000004162
Date of registration:	05/09/2010
Prospective Registration:	No
Primary sponsor:	Faculty of Life Sciences, Kumamoto University
Public title:	The efficacy of Mizoribine for scleroderma of systemic sclerosis.
Scientific title:	The efficacy of Mizoribine for scleroderma of systemic sclerosis. - The efficacy of Mizoribine for scleroderma of systemic sclerosis.
Date of first enrolment:	2010/09/01
Target sample size:	10
Recruitment status:	Recruiting
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004987
Study type:	Interventional
Study design:	Parallel Randomized
Phase:	Not selected

Countries of recruitment
Japan

Contacts

Name:	Hironobu Ihn
Address:	1-1-1 Honjo Kumamoto city Japan
Telephone:
Email:
Affiliation:	Faculty of Life Sciences, Kumamoto University Department of Dermatology and Plastic Surgery

Name:	Takamitsu Makino
Address:	1-1-1 Honjo Kumamoto city Japan
Telephone:
Email:
Affiliation:	Faculty of Life Sciences, Kumamoto University Department of Dermatology and Plastic Surgery

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: The cases of hypersensitivity for Mizoribine.

Age minimum: Not applicable
Age maximum: Not applicable
Gender: Male and Female

Health Condition(s) or Problem(s) studied

systemic sclerosis

Intervention(s)

a group of Mizoribine
a group of the existing treatment

Primary Outcome(s)

skin screlosis

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date:
Contact:

Results

Results available:	Yes
Date Posted:
Date Completed:	30/11/2014
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.